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Abstract 26 
Keratinocyte cornification and epidermal barrier formation are tightly controlled processes, which 27 
require complete degradation of intracellular organelles, including removal of keratinocyte nuclei. 28 
Keratinocyte nuclear destruction requires Akt1-dependent phosphorylation and degradation of the 29 
nuclear lamina protein, Lamin A/C, essential for nuclear integrity. However, the molecular 30 
mechanisms that result in complete nuclear removal and their regulation are not well defined. Post-31 
confluent cultures of rat epidermal keratinocytes (REKs) undergo spontaneous and complete 32 
differentiation, allowing visualisation and perturbation of the differentiation process in vitro. We 33 
demonstrate that there is dispersal of phosphorylated Lamin A/C to structures throughout the 34 
cytoplasm in differentiating keratinocytes. We show that the dispersal of phosphorylated Lamin A/C 35 
is Akt1-dependent and these structures are specific for the removal of Lamin A/C from the nuclear 36 
lamina; nuclear contents and Lamin B were not present in these structures. Immunoprecipitation 37 
identified a group of functionally related Akt1 target proteins involved in Lamin A/C dispersal, 38 
including actin, which forms cytoskeletal microfilaments, Arp3, required for actin filament 39 
nucleation, and Myh9, a component of myosin IIa, a molecular motor that can translocate along 40 
actin filaments. Disruption of actin filament polymerisation, nucleation or myosin IIa activity 41 
prevented formation and dispersal of cytoplasmic Lamin A/C structures. Live imaging of 42 
keratinocytes expressing fluorescently tagged nuclear proteins showed a nuclear volume reduction 43 
step taking less than 40 minutes precedes final nuclear destruction. Preventing Akt1-dependent 44 
Lamin A/C phosphorylation and disrupting cytoskeletal Akt1-associated proteins prevented nuclear 45 
volume reduction. We propose keratinocyte nuclear destruction and differentiation requires myosin 46 
II activity and the actin cytoskeleton for two intermediate processes: Lamin A/C dispersal and rapid 47 
nuclear volume reduction. 48 
  49 
 4
Introduction 50 
The mammalian epidermis is an essential barrier between an organism and its environment1,2. The 51 
epidermis has four layers of keratinocytes: basal, spinous, granular and cornified, the last of which is 52 
comprised of corneocytes3,4. Formation of a healthy skin barrier requires continual differentiation of 53 
epidermal keratinocytes into corneocytes4. Transition of keratinocytes from granular layer cells to 54 
corneocytes is a highly controlled and irreversible terminal process. As part of this, keratinocytes 55 
undergo major morphological changes, involving removal of all their intracellular organelles, 56 
including nuclei, allowing corneocytes to contain an extremely high proportion of keratin and form 57 
the rigid outer epidermal cell layer4,5. 58 
Disruption of nuclear degradation leading to retention of nuclei in the cornified layer, known as 59 
parakeratosis, is a frequent observation in many skin diseases6,7; however, the mechanisms by which 60 
keratinocytes remove their nuclei are not well defined4,8. Nuclear removal is dependent on Akt1 61 
kinase. Akt1 shRNA knockdown decreased phosphorylation of the nuclear lamina component Lamin 62 
A/C, decreased Lamin A/C degradation, and increased nuclear retention in the cornified layer9,10. 63 
Subsequent to nuclear lamina breakdown, DNA degrading enzymes are required for nuclear 64 
breakdown; murine epidermis lacking DNase1L2 and DNase2 is parakeratotic, however the 65 
parakeratotic nuclei lack Lamin A/C indicating DNA degradation occurs after lamina removal11. 66 
Proteins important in autophagic processes are also required for removal of nuclear content; 67 
dysregulation of autophagy-related proteins correlates with decreased nuclear degradation and the 68 
autophagic marker LC3 localises close to the nucleus in differentiating cells12,13. 69 
The transition from granular keratinocytes to corneocytes occurs over a 24 hour period, with the 70 
nuclear removal process estimated to take 6 hours4,14. However, the mechanisms preceding removal 71 
of the nucleus are currently unidentified8. Using rat epidermal keratinocytes (REKs), which 72 
spontaneously differentiate in submerged culture, we have followed nuclear degradation in an in 73 
vitro model without forced initiation of differentiation by calcium switch. We identified Akt1-74 
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dependent dispersion of nuclear lamina components throughout the cytoplasm in differentiating 75 
keratinocytes that precedes nuclear degradation. Following fluorescently tagged nuclear proteins in 76 
real time has allowed us to identify rapid nuclear shrinkage as an important nuclear degradation 77 
intermediate. We also isolated a ‘degradosome’ complex of proteins that associate with Akt1, 78 
including actin and the actin-binding proteins Myh9 and Arp3 that are involved in nuclear removal. 79 
These results provide evidence for two nuclear degradation intermediates in keratinocyte 80 
differentiation and the characterisation of a protein complex important for nuclear degradation 81 
regulation. 82 
 83 
Materials and Methods 84 
Antibodies and materials 85 
The following commercially available antibodies were used: Actin (Sigma-Aldrich, A2066), β-Actin 86 
(Millipore, MAB1501R), Akt (Cell Signaling Technology, 4691), Akt1 (Cell Signaling Technology, 2967), 87 
Arp3 (Santa Cruz Biotechnology, sc-48344), COPS4 (Invitrogen, PA5- 57863), FAK1 (Abgent, 88 
AP7715a), FLAG (Sigma-Aldrich, F3165), GAPDH Millipore Sigma MAB374, GFP (Santa Cruz 89 
Biotechnology, sc-9996), Histone H2B (Santa Cruz Biotechnology, sc-515808), Histone H3.1 (Santa 90 
Cruz Biotechnology, sc-517576), HspB1 (Abcam, ab12351), Jup (Santa Cruz Biotechnology, SC-91 
514115), K10 (BioLegend, 905401), Lamin A (Santa Cruz Biotechnology; sc-376248, sc-398927, sc-92 
518013), Lamin B1 (Abcam, ab16048), Loricrin (BioLegend, 905101), Myh9 (GeneTex, GTX113236), 93 
phospho-(Ser/Thr) Akt substrate (Cell Signaling Technology, 9611), Plectin (Santa Cruz 94 
Biotechnology, sc-33649), Ran (Santa Cruz Biotechnology, sc-271376) and STAMBP (Biorbyt, 95 
ORB341234). An antibody to pSer404 of Lamin A was raised in rabbit to phosphopeptide CGRASp-96 
SHSSQTQGGG by Mimotopes (UK) Ltd, and another was a gift from Sandra Marmiroli (Figure 1D, 2D 97 
and F, 7A). Alexa Fluor 568 Phalloidin was from Thermo Fisher Scientific. EGFP-Lamin A was a gift 98 
from Pekka Taimen. Lamin A-mEmerald (mEmerald-LaminA-N-18) and NLS-mCherry (mCherry-99 
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Nucleus-7) were gifts from Michael Davidson (Addgene plasmids #54139 and #55110, unpublished). 100 
Histone H2B-mCherry was a gift from Robert Benezra (Addgene plasmid #20972,15). FLAG-tagged 101 
S404A, S404D and WT Lamin A constructs were a gift from Sandra Marmiroli. shRNA constructs were 102 
obtained from QIAGEN (SureSilencing Akt1 shRNA plasmids) or Origene (HuSH Myh9 shRNA 103 
constructs). 104 
Cell culture 105 
REKs were cultured in DMEM supplemented with 10% FBS, 1% penicillin/streptomycin at 37 °C and 106 
5% CO2 and tested regularly to ensure cultures are free from Mycoplasma infection. Normal human 107 
epidermal keratinocytes were cultured in Epilife medium (Sigma Aldrich) and keratinocytes were 108 
differentiated by treatment with 1.2 mM calcium chloride for 4 days. For transfection, cells were 109 
transfected with Lipofectamine 2000 (Invitrogen) or jetOptimus (Polyplus transfection) according to 110 
manufacturers’ guidelines one day after seeding. After transfection with Akt1 (Qiagen)16 or Myh9 111 
shRNA plasmids (HuSH constructs, Insight Biotechnology), knockdown REKs were selected for by 112 
addition of G418 (400 µg/ml) or puromycin (1.25 µg/ml), respectively, to the medium for 10 days. 113 
Upon confluency REKs were fed every day and cultures fixed 2-4 days post confluency to analyse 114 
differentiation. Organotypic models were cultured and processed as described10. Treatments were 115 
performed upon confluency for 24 hours: 10 nM Rapamycin (Cell Signaling Technology, 9904S), 50 116 
µM Blebbistatin (Millipore, 203389), 1 µM Latrunculin B (Calbiochem, 428020), 50 µM CK666 117 
(Abcam, ab141231) and 20 µM Q-VD-OPh. 118 
Western blotting 119 
Cells were lysed in total lysis buffer (20% β-mercaptoethanol, 5% sodium dodecyl sulphate (SDS), 10 120 
mM Tris pH 7) and boiled for 10 min at 95°C. Protein lysates were separated on 4-20% SDS-121 
polyacrylamide gels (Bio-Rad) and transferred to nitrocellulose membrane before blocking and with 122 
5% milk (Marvel) or bovine serum albumin (Sigma) w/v in PBS-T (0.1% Tween-20 in PBS). The 123 
blocked membrane was probed with primary and HRP-linked secondary antibodies (Dako) diluted in 124 
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the blocking buffer. Luminol (Santa Cruz Biotechnology) was used to detect protein bands and 125 
results were analysed with Fiji17. 126 
Co-immunoprecipitation 127 
Cells were lysed in RIPA buffer (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 1% Triton X-100, 0.1% sodium 128 
deoxycholate, 0.5% SDS) and immunoprecipitation carried out using the Dynabeads Protein G 129 
Immunoprecipitation Kit (Thermo Fisher Scientific) according to the manufacturer’s instructions. 130 
Eluted proteins and controls were analysed by western blotting or Coomassie Blue staining (Fisher). 131 
Immunocytochemistry 132 
REK monolayer cultures were fixed in 4% PFA 0.2% triton X-100 or -20 °C methanol. Blocking was 133 
performed with 0.4% fish skin gelatin in PBS with 0.2% Triton X-100 and primary and Alexa fluor-134 
conjugated secondary antibodies were diluted in blocking solution. Samples were counterstained 135 
with DAPI, mounted with Prolong Gold (Life Technologies) and imaged on Leica DM5000B 136 
epifluorescence (Leica Microsystems, Milton Keynes, UK) and Zeiss LSM880 Airyscan (Zeiss, 137 
Cambridge, UK) laser confocal microscopes. Analysis was performed in Fiji; pSer404 Lamin A 138 
dispersing cells were counted using the ImageJ Cell Counter plugin, Lamin B1 shrunken nuclei were 139 
thresholded and then counted using the Analyze Particles plugin. 140 
Fluorescent immunohistochemistry 141 
Organotypic culture sections, wild-type neonatal C57BL6 murine sections, and human skin sections 142 
(5 µm) were dewaxed and antigens retrieved in boiling 0.01 M sodium citrate pH 7 for 7 min. 0.4% 143 
fish skin gelatin 0.2% Triton X-100 in PBS blocking buffer was also used for primary and secondary 144 
antibody dilutions. Samples were mounted with Prolong Gold with DAPI (Life Technologies) and 145 
imaged on Leica DM5000B epifluorescence and Zeiss LSM880 Airyscan confocal microscopes. 146 
Live imaging 147 
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REKs transfected with fluorescently tagged proteins were seeded in CELLview™ Cell Culture Dishes 148 
and allowed to reach confluency and then cultured for a further 3-4 days before imaging. Confocal 149 
images were taken every 15/20 min on a Zeiss LSM880 Airyscan confocal microscope. Images were 150 
processed and analysed using Fiji.  151 
Flow cytometry and cell sorting 152 
Post-confluent REK cultures were dissociated in trypsin, resuspended in PBS with Hoechst 33342 and 153 
incubated for 45 min at 37 °C. Flow cytometry was performed on a FACS Canto II (BD Biosciences, 154 
San Jose, USA) and analysed with FlowJo (BD). Cells were sorted, without Hoechst incubation, on a 155 
FACSAria IIIu Cell Sorter (BD Biosciences). 156 
Mass spectrometry 157 
Collodial coomassie dye stained acrylamide gel bands were destained and digested using the 158 
method as reported18. The extracted peptides were further cleaned using C18+carbon top tips 159 
(Glygen corporation, TT2MC18.96) and eluted with 70% acetonitrile (ACN) with 0.1% formic acid.  160 
Dried peptides were dissolved in 0.1% TFA and analysed by nanoflow ultimate 3000 RSL nano 161 
instrument was coupled on-line to a Q Exactive plus mass spectrometer (Thermo Fisher Scientific, 162 
Waltham, USA). Gradient elution was from 3% to 35% buffer B in 120 min at a flow rate 250nL/min 163 
with buffer A being used to balance the mobile phase (buffer A was 0.1% formic acid in water and B 164 
was 0.1% formic acid in ACN) . The mass spectrometer was controlled by Xcalibur software (version 165 
4.0) and operated in the positive mode. The spray voltage was 1.95 kV and the capillary temperature 166 
was set to 255 ºC. The Q-Exactive plus was operated in data dependent mode with one survey MS 167 
scan followed by 15 MS/MS scans. The full scans were acquired in the mass analyser at 375- 168 
1500m/z with the resolution of 70 000, and the MS/MS scans were obtained with a resolution of 17 169 
500.  170 
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MS raw files were converted into Mascot Generic Format using Mascot Distiller (version 2.5.1) and 171 
searched against the SwissProt database restricted to Rat entries using the Mascot search daemon 172 
(version 2.5.0) with a FDR of ~1% and restricted to the human entries. Allowed mass windows were 173 
10 ppm and 25 mmu for parent and fragment mass to charge values, respectively. Variable 174 
modifications included in searches were oxidation of methionine, pyro-glu (N-term) and 175 
phosphorylation of serine, threonine and tyrosine. The mascot result (DAT) files were extracted into 176 
excel files for further normalisation and statistical analysis.  177 
 178 
Results 179 
Akt1-dependent dispersal of phosphorylated lamina proteins in keratinocyte differentiation 180 
Akt1 is required for Lamin A/C phosphorylation and Akt1 knockdown prevents Lamin A/C 181 
degradation and nuclear removal, suggesting Lamin A/C phosphorylation is important for nuclear 182 
lamina breakdown in keratinocyte nuclear removal10. Phosphorylated serine 404 (pSer404) Lamin 183 
A/C disperses to intracellular structures in granular layer cells in human and murine skin sections and 184 
REK organotypic cultures10, (Supplementary Figure 1A). We determined that pSer404 Lamin A/C 185 
dispersal to cytoplasmic structures also occurred in suprabasal, differentiating REKs in monolayer 186 
culture, (Figure 1A and B) and calcium switched human keratinocytes, (Figure 1C), although these 187 
structures were less developed. Akt1 co-localised with pSer404 Lamin A/C at the nucleus and at 188 
dispersed structures throughout the cytoplasm, (Figure 1D). Lamin A/C dispersal was reduced in 189 
Akt1 knockdown REK organotypic cultures10, suprabasal Akt1 knockdown REKs had increased nuclear 190 
size in post-confluent cultures compared to controls10, (Figure 1E-H), and suprabasal differentiating 191 
cells are larger and less granular based on flow cytometry side scatter (SSC) measurements, (Figure 192 
1G-L). Conversely, rapamycin treatment, which increases Akt1 activity19, increased the number of 193 
cells with Lamin A/C dispersal, (Figure 1M and N). Akt1 activity is therefore required for Lamin A/C 194 
dispersal and nuclear degradation. Overexpression of myristoylated Akt1 (Myr-Akt1) did not increase 195 
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the number of cells with Lamin A/C dispersal, but accumulated at the nucleus and increased pSer404 196 
Lamin A/C intensity, suggesting a role for Akt1 in initiation of Lamin A/C dispersal before a separate 197 
dispersal step, (Supplementary Figure 1B-D) 198 
Overexpression of ‘non-AKT-phosphorylatable’ S404A Lamin A decreased Lamin A/C dispersal, 199 
(Figure 1O and P), and reduced expression of the keratinocyte differentiation marker loricrin, 200 
(Supplementary Figure 1E and F). This suggested that Akt1-dependent phosphorylation of Lamin A/C 201 
also affected differentiation. Overexpression of ‘phosphomimetic’ S404D Lamin A did not increase 202 
Lamin A/C dispersal, nor did it increase Loricrin staining or alter nuclear size, (Supplementary Figure 203 
1G-I). This construct did have a lower transfection efficiency, (Supplementary Figure 1J), suggesting 204 
an intolerance to the expression of the phosphomimetic construct, or alternatively, the majority of 205 
Lamin A/C is phosphorylated, and so the system is not affected by the phosphomimetic. 206 
Lamina dispersal is specific to Lamin A/C 207 
Dispersed pSer404 Lamin A/C structures did not contain any identifiable nuclear content; they did 208 
not consistently stain with the DNA intercalating dye DAPI and did not co-localise with Histone 209 
proteins, either endogenous Histone H3 or H2B or an overexpressed Histone H2B-mCherry, (Figure 210 
2A-D). Ran, a nuclear transport protein, dispersed to pSer404 Lamin A/C cytoplasmic structures, 211 
(Figure 2E), indicating their origin at the nucleus. However, the structures did not contain mCherry 212 
targeted to the nucleus with a nuclear localisation sequence (NLS-mCherry), (Figure 2F); indicating 213 
these structures did not contain functional nuclear pores. Additionally, Lamin B1 did not disperse to 214 
cytoplasmic Akt1-containing structures, (Figure 2G); suggesting Lamin A/C but not Lamin B1 is 215 
involved in this process. 216 
Dispersal of Akt1 and pSer404 Lamin A/C was similar to the previously identified cytoplasmic 217 
distribution of filaggrin in differentiating keratinocytes20 and Akt1 showed some co-localisation with 218 
filaggrin in suprabasal keratinocytes, (Figure 2H). 219 
Akt1-associated proteins form a ‘degradosome’ complex in differentiating REKs 220 
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AKT family kinases have a large number of downstream target proteins involved in a wide range of 221 
cellular processes that may be tissue, cell and cellular location specific21, suggesting the potential of 222 
novel Akt1-interacting proteins being involved in lamin dispersal and nuclear shrinkage. To explore 223 
this we performed immunoprecipitation with an Akt1-specific antibody, followed by mass 224 
spectrometric analysis of eight major SDS-PAGE gel bands. Excluding mitochondrial and keratin 225 
proteins, we identified 21 potential Akt1-interacting partners in REKs (Figure 3A and B), including the 226 
previously identified Akt1 target, HspB19. STRING analysis of these candidates identified several 227 
previously identified interactions or links between these proteins, (Figure 3C). Co-staining with Akt1 228 
or pSer404 Lamin A antibodies demonstrated co-localisation or adjacent expression on cytoplasmic 229 
structures for filamentous actin (phalloidin), Arp3, Cops4, Myh9, Ran, Jup and Stambp, (Figures 2E 230 
and 3D-I). Staining of mouse epidermis indicated co-expression of dispersed Akt1 or pSer404 Lamin 231 
A staining with Myh9, Ran and Stambp in suprabasal keratinocyte layers, (Figure 4A-C). 232 
Immunoprecipitation confirmed β-actin, Arp3, and Myh9 interacted with Akt1 (Figure 4D). The 233 
difference in apparent molecular weight for immunoprecipitated Myh9 may be due to 234 
phosphorylation, potentially Akt1-dependent phosphorylation, as Myh9 was pulled down by an 235 
antibody directed to Akt phosphorylation sites, (Figure 4E). These results suggest functionally related 236 
Akt1 interactors suggestive of a ‘degradosome’ complex including actin and the actin-binding 237 
proteins, Myh9 and Arp3, associating with Akt1 and with cytoplasmic pSer404 Lamin A in 238 
differentiating REKs, (Figure 4F). Myh9 is a component of myosin IIa, a molecular motor that can 239 
translocate along actin filaments, and Arp3 is a component of the Arp2/3 complex required for actin 240 
filament nucleation22,23. This suggests a dependence on the actin cytoskeleton and actin-binding 241 
proteins for Akt1 function in epidermal terminal differentiation. 242 
Akt1-associated actin remodelling is required for nuclear degradation 243 
To test the requirement for actin and myosin II motors in nuclear degradation, we chemically 244 
disrupted their function; using latrunculin B to block actin polymerisation and blebbistatin to inhibit 245 
myosin II activity in post-confluent REKs. Latrunculin B and blebbistatin treatment inhibited Lamin 246 
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A/C dispersal to the cytoplasm, (Figure 5A and B), and increased nuclear size in large granular 247 
differentiating REKs, (Figure 5D-E and Supplementary Figure 2A-B). These treatments did not affect 248 
levels of phosphorylated full length, and cleaved, Lamin A/C in post-confluent REK cultures, (Figure 249 
5C, F and G). Treatment with CK666, an Arp2/3 specific inhibitor decreased phosphorylated Lamin 250 
A/C and dispersal at 50 µM, (Figure 5H-J) but had no significant effect on nuclear size, (Figure 5K, L 251 
and Supplementary Figure 2C).  252 
Myh9 (myosin IIa) shRNA knockdown (Figure 5M) also decreased phosphorylated Lamin A/C 253 
dispersal, (Figure 5N-P) and increased nuclear size, (Figure 5Q-R). This suggested that the activity of 254 
myosin II and the presence of the actin cytoskeleton is required for the formation and/or 255 
distribution of cytoplasmic Lamin A/C structures after Akt1-dependent phosphorylation of Lamin 256 
A/C.  257 
Fluorescently tagged nuclear proteins illustrate nuclear shrinkage in REKs 258 
To understand how Lamin A/C dispersal occurs in suprabasal differentiating REKs we expressed 259 
fluorescently tagged nuclear proteins and imaged at least three days post-confluency to follow 260 
changes in nuclear morphology in real time. The majority of EGFP-Lamin A positive REKs did not alter 261 
in nuclear size/maximum cross-sectional area over 11 hours, (Movie 1). However, 10% of nuclei 262 
rapidly decreased in size, within 40 min, (Movie 2 and Figure 6A-C). There is no further decrease in 263 
size after this, (Figure 6B and C), and this is a decrease in nuclear volume not just due to rotation of 264 
the nucleus, (Figure 6D). There was no change in signal intensity in EGFP-Lamin A expressing nuclei 265 
that had shrunk (Figure 6C), although, DAPI and Lamin A/C staining intensity decreased in suprabasal 266 
shrunken nuclei compared to basal ‘non-shrunken nuclei’ in fixed post-confluent REKs, (Figure 6E-H). 267 
Conversely, apparent Lamin B1 staining intensity increased in shrunken nuclei, (Figure 6I).  268 
In post-confluent H2B-mCherry expressing REKs approximately one quarter of labelled nuclei rapidly 269 
decreased in surface area, (Figure 6J-K and Supplementary Figure 3A-C), with an average decrease in 270 
nuclear volume of 68.5%, (Figure 6M-N). mCherry signal intensity decreased over time in shrunken 271 
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nuclei, compared to ‘non-shrunken’ nuclei, until the signal was lost in 41.6% of shrunken nuclei, 272 
(Figure 6L and Supplementary Figure 3C). Similarly to nuclei expressing EFGP-Lamin A, there was no 273 
decrease in mCherry or EGFP signal over 10 hours in shrunken nuclei of REKs co-expressing Histone 274 
H2B-mCherry and EGFP-Lamin A (Supplementary Figure 3D-F). This indicated that nuclear shrinkage 275 
occurs before nuclear content degradation, and continued expression of Lamin A/C prevented 276 
nuclear degradation after shrinkage. 277 
Phosphorylated Lamin A/C is cleaved prior to cytoplasmic dispersal  278 
Interestingly, EGFP-Lamin A did not disperse to cytoplasmic structures in live imaging experiments 279 
and EGFP-Lamin A did not co-localise with dispersed pSer404 Lamin A, (Figure 7A), suggesting that 280 
cleavage of Lamin A may occur before dispersal to the cytoplasm. Two cysteine protease cleavage 281 
sites have been predicted for Lamin A/C: Asp230 and Asp446, with cleavage during apoptosis at 282 
Asp23024,25. Western blots of post-confluent EGFP-Lamin A expressing REKs (N-terminal EGFP tag) 283 
and in Lamin A-mEmerald expressing REKs (C-terminal Emerald tag) demonstrated Lamin A 284 
fragments of approximately 55 and 80 kDa, respectively, which would be consistent with cleavage of 285 
Lamin A around Asp230, (Figure 7B and Supplementary Figure 4A-C). An antibody targeted to the 286 
Lamin A/C N-terminus did not stain cytoplasmic pSer404 Lamin A structures, (Figure 7C). This 287 
indicates only the C-terminal Lamin A/C degradation product, containing the Ser404 phosphorylation 288 
site, is targeted to cytoplasmic structures. 289 
Nuclei expressing C-terminally tagged Lamin A/C, Lamin A-mEmerald, underwent nuclear shrinkage 290 
with the same kinetics as EGFP-Lamin A expressing REKs, (Supplementary Figure 4D-G), but Lamin A-291 
mEmerald also did not disperse, (Supplementary Figure 4H). Lamin A/C contains a C-terminal CAAX 292 
box required for farnesylation before prelamin A/C cleavage, which is necessary for functional 293 
integration into the nuclear lamina26–28. Prevention of CAAX box modification and/or cleavage by 294 
presence of the C-terminal mEmerald tag may prevent correct Lamin A-mEmerald integration into 295 
the nuclear lamina. Consistent with this, nuclei expressing Lamin A-mEmerald had a disrupted 296 
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nuclear lamina compared to EGFP-Lamin A expressing nuclei, (Supplementary Figure 4I). Caspase 297 
inhibition did not affect pSer404 Lamin A dispersal in post-confluent REK cultures (Supplementary 298 
Figure 4J and K). 299 
The actomyosin cytoskeleton is required for nuclear shrinkage and epidermal differentiation 300 
We tested the dependence of nuclear shrinkage on the activity of Akt1-associated cytoskeletal 301 
proteins. Blebbistatin treatment reduced the number and increased the nuclear size of shrunken 302 
Lamin B1-positive nuclei, (Figure 7D-F), indicating myosin II activity is required for Lamin A/C 303 
dispersal and nuclear shrinkage. Latrunculin B treatment also increased the size of nuclei that had 304 
high nuclear Lamin B1 expression, (Figure 7D and F), but latrunculin B and CK666 treatment did not 305 
affect the number of cells with high Lamin B1 expression, (Figure 7E, K-M). Both blebbistatin and 306 
latrunculin B treatments reduced loricrin expression and affected differentiated keratinocyte 307 
morphology, reducing the size of loricrin expressing keratinocytes, (Figure 7G-J). 308 
Myh9 shRNA knockdown did not significantly affect nuclear shrinkage, (Figure 8A-B), but did 309 
decrease loricrin expression, (Figure 8C-D). Myh9 knockdown organotypic cultures had decreased 310 
Myh9 expression, (Figure 8H), were hyperkeratotic and displayed small parakeratotic nuclear 311 
material, (Figure 8E-G, I). Fewer cells underwent Lamin A/C dispersal, (Figure 8J-K), but there was no 312 
detectable change in loricrin expression, (Figure 8L). Defects in Lamin A/C dispersal and 313 
differentiation without defects in nuclear shrinkage may indicate that other mechanisms also affect 314 
nuclear shrinkage. 315 
 316 
Discussion 317 
We present data suggesting that nuclear degradation in mammalian epidermal keratinocytes 318 
requires Akt1-dependent phosphorylation and cleavage of Lamin A/C before actin cytoskeleton and 319 
myosin II mediated cytoplasmic dispersal of pSer404 Lamin A/C. Lamina removal from the nucleus 320 
precedes nuclear shrinkage and then nuclear content degradation. Akt1 and its interactors act as 321 
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part of a ‘degradosome’ complex required for two novel nuclear removal intermediate processes 322 
during keratinocyte nuclear destruction: Lamin A/C dispersal and rapid nuclear volume reduction. 323 
Lamins A/C and B1/2 are important components of the nuclear lamina, where they regulate nuclear 324 
morphology29–32 and control chromatin organisation with the lamin B receptor33. They interact with 325 
DNA through lamina-associated domains (LADs), which are enriched in transcriptionally repressed 326 
areas of the genome34. Various models of lamin association with LADs have been proposed, 327 
including direct tethering to chromatin domains35 and a ‘meshwork caging model’ where the dense 328 
lamin network traps chromatin domains36,37.  Work in Lamin null mice demonstrated that loss of 329 
LADs altered chromatin organisation and affected gene expression in neighbouring ‘non-LAD’ 330 
genomic regions38. Interestingly, murine skin develops normally without Lamin B1 or B2 expression39 331 
and A and B-type lamins have been suggested to have different functions in chromatin organisation 332 
and gene expression regulation40–42. We demonstrated that Lamin A/C is specifically dispersed to 333 
cytoplasmic structures, which do not contain DNA, histone proteins, NLS-targeted protein or Lamin 334 
B1. The specific removal of Lamin A/C from the nuclear periphery may specifically alter keratinocyte 335 
gene expression to regulate subsequent stages in keratinocyte differentiation. 336 
Our data suggests cleavage of Lamin A/C occurs prior to dispersal from the nucleus, and only the C-337 
terminal fragment of Lamin A/C disperses to the cytoplasm. C-terminally tagged Lamin A-mEmerald 338 
was not dispersed, however, the C-terminal tag is likely to affect correct Lamin A/C processing at the 339 
C-terminal CAAX box28. Progerin, a C-terminal mutant form of Lamin A/C43, retains modifications at 340 
the CAAX box and is not correctly cleaved, altering nuclear lamina structure and nuclear 341 
morphology44,45. Therefore, the C-terminal mEmerald tag may prevent correct integration into the 342 
nuclear lamina; affect nuclear morphology, Lamin A/C phosphorylation and/or cleavage and 343 
dispersal. 344 
We identified myosin IIA activity and the actin cytoskeleton as important for epidermal 345 
differentiation and Lamin A/C dispersal. Myosin II activity is required for nuclear repositioning in cell 346 
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migration46, constriction of the cytokinetic actomyosin contractile ring47–49 and contraction of an 347 
actin network around the nucleus at nuclear envelope breakdown50. Arp2/3, required for branched 348 
actin filament nucleation, has previously been identified as required for epidermal 349 
differentiation51,52, regulation of nuclear actin53 and correct formation of the actomyosin contractile 350 
ring in cell division54.  Myosin IIA and Arp2/3 have also been identified as responsible for force 351 
generation in the secretion of vesicles in alveolar type II (ATII) cells55 and myosin IIA and actin are 352 
required for exocytosis in murine exocrine cells56.  Disrupting myosin II and Arp2/3 activity affected 353 
lamin dispersal, however, whether their activity is important for force generation for formation of 354 
cytoplasmic pSer404 Lamin A/C structures or for trafficking of these structures will be important to 355 
determine. 356 
Dispersed Akt1 in the cytoplasm of differentiating keratinocytes also coincided with dispersed 357 
filaggrin, which may indicate filaggrin may also be a component of the Akt1-interacting complex or 358 
‘degradosome’. Filaggrin processing is tightly regulated and required for healthy epidermal 359 
differentiation57,58. We previously identified that upon decreased Akt1 activity, expression of 360 
Cathepsin H decreased, and Cathepsin H deficiency in heterozygous murine models impaired 361 
filaggrin processing, caused barrier defects and altered keratinocyte differentiation16. Additionally, 362 
overexpression of a filaggrin N-terminal construct in COS7 cells affected nuclear integrity, leading to 363 
punctate filaggrin and lamin immune-positive structures throughout the cytoplasm59. This also 364 
correlates with the actomyosin cytoskeletal dependence of Lamin A/C dispersal, as Akt1 influences 365 
filaggrin-actin interactions and is essential for filaggrin processing9,20. The parallel structures and the 366 
changes in filaggrin localisation in Cathepsin H knockout mice may indicate that Akt1-dependent 367 
lamin degradation and control of filaggrin processing may be interlinked and would be an interesting 368 
avenue to pursue. 369 
Our results suggest another nuclear degradation intermediate of a ‘shrunken nucleus’, which may be 370 
the major morphological alteration in nuclear removal. Dispersion of cleaved Lamin A/C without 371 
dispersal of nuclear contents prior to nuclear shrinkage suggests that degradation and removal of 372 
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nuclear lamina proteins may be an initial step in the initiation of nuclear removal. REKs expressing 373 
GFP-tagged Lamin A undergo nuclear shrinkage, but do not undergo further degradation. REKs 374 
expressing Histone H2B-mCherry underwent nuclear shrinkage followed by a gradual decrease in 375 
signal intensity, suggesting degradation of nuclear contents. This suggests decreased expression of 376 
Lamin A/C at the nuclear lamina is required for nuclear content degradation. Lamin A/C and Lamin 377 
B1 form separate but interconnecting networks60 and perform distinct functions at the nuclear 378 
lamina; Lamin A/C deficient nuclei have decreased nuclear stiffness and increased deformations 379 
whereas Lamin B1 deficient nuclei display normal nuclear mechanics30. Protein and lipid depleted 380 
nuclear matrices have been shown to reversibly shrink in response to bivalent cation concentration61 381 
or nuclease treatment62,63 and isolated rat nuclei shrink in response to elevated calcium levels64. 382 
Degradation of nuclear material occurs after Lamin A/C depletion of the nucleus, as DNase deficient 383 
murine epidermis retains DAPI but not Lamin A/C staining in corneocytes11. Therefore, removal of 384 
Lamin A/C may allow subsequent changes in nuclear morphology by altering the stiffness of the 385 
lamina, and/or by allowing access for molecules necessary for nuclear content degradation. 386 
Overexpression of GFP-tagged Lamin A/C constructs inhibited nuclear content degradation and Akt1 387 
or Myh9 knockdown organotypics contained parakeratotic nuclei, demonstrating impaired nuclear 388 
removal. This indicated that Lamin A/C cleavage and dispersal are required for complete nuclear 389 
removal. Disruption of myosin activity and the actin cytoskeleton, through blebbistatin, latrunculin B 390 
and CK666 treatment and Myh9 (myosin IIA) knockdown affected lamin dispersal and increased 391 
nuclear size in differentiating keratinocytes. However, only blebbistatin treatment affected the 392 
number of shrunken Lamin B1 expressing nuclei in our post-confluent REK cultures, suggesting that 393 
although removal of Lamin A/C from the nuclear periphery is essential for nuclear degradation and 394 
keratinocyte differentiation it is not required for nuclear shrinkage. Nuclear shrinkage may be 395 
independently controlled by myosin IIB and IIC, which have some partially redundant properties but 396 
distinct cellular localisations65–69 to myosin IIA. 397 
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Targeted autophagy of the nucleus, nucleophagy, is required for keratinocyte nuclear removal; with 398 
localisation of LC3 and autophagosomes to indentations at the nuclear periphery of differentiating 399 
keratinocytes12. Additionally, impaired clearance of nuclear material by autophagosomes was 400 
identified in laminopathies, diseases with mutations in lamina proteins13, suggesting that alterations 401 
to nuclear lamina structure are key for nuclear destruction. We suggest that dispersal of pSer404 402 
Lamin A/C to cytoplasmic structures and nucleophagic processes at the nuclear periphery may act 403 
concurrently to complete nuclear removal. 404 
Identification of the molecular mechanisms that initiate and are involved in nuclear removal would 405 
be important for understanding and treating parakeratotic skin diseases. However, this could also be 406 
of wider importance in other cell types to prevent cellular processes including proliferation and to 407 
activate cell death by programmed nuclear clearance. We hope that further delineation of the 408 
processes leading to nuclear removal in healthy epidermis will advance this aim. 409 
 410 
Supplementary information is available at the Cell Death & Differentiation website.  411 
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 Figure Legends 594 
Figure 1 – Phosphorylated Lamin A in keratinocyte differentiation and nuclear degradation. 595 
A – pSer404 Lamin A/C staining in single confocal sections of basal and suprabasal REKs. Scale bars = 596 
20 µm. 597 
B - pSer404 Lamin A/C signal colour-coded according to the frame of the z-stack. Yellow = basal 598 
signal, blue and pink = more suprabasal signal. Scale bar = 20 µm.  599 
C – pSer404 Lamin A/C staining in single confocal sections of undifferentiated and calcium switched 600 
differentiated human keratinocytes. Scale bars = 20 µm. 601 
D - Akt1 co-localises with pSer404 Lamin A/C in a single confocal section of suprabasal REKs. Box 602 
indicates enlarged area, scale bar = 20 µm.  603 
E – Representative area of Hoechst 33342 staining (nuclear content) of control or Akt1 knockdown 604 
(kd) REKs. 605 
F – Median area of Hoechst 33342 staining (nuclear content) of control or Akt1 knockdown REKs, in 606 
triplicate * p ≤ 0.05. 607 
G – Representative area of Hoechst 33342 staining of control or Akt1 knockdown large 608 
differentiating REKs, gated on high FSC and SSC. 609 
H - Median area of Hoechst 33342 staining of control or Akt1 knockdown large differentiating REKs, 610 
in triplicate * p ≤ 0.05. 611 
I - Representative FSC-A (Area) area of control or Akt1 knockdown large differentiating REKs. 612 
J – Median FSC-A in control or Akt1 knockdown large differentiating REKs, in triplicate *** p ≤ 0.001. 613 
K – Representative SSC-A (Area) of control or Akt1 knockdown large differentiating REKs. 614 
L – Median SSC-A in control or Akt1 knockdown large differentiating REKs, in triplicate *** p ≤ 0.001. 615 
M – DMSO or Rapamycin treated post-confluent REKs stained for pSer404 Lamin A/C. Maximum 616 
projections of confocal z-stacks, scale bar = 50 µm.  617 
N - Number of cells with dispersed pSer404 Lamin A/C per field of view (FOV), 2 independent 618 
experiments, ≥4 FOV, Welch’s t test, ** p ≤ 0.01. 619 
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O – REKs expressing WT or S404A Lamin A stained for pSer404 Lamin A/C. Epifluorescence image, 620 
scale bar = 50 µm.  621 
P - Number of cells with dispersed pSer404 Lamin A/C per FOV compared to WT Lamin A. Two 622 
independent experiments, three FOV per experiment, Welch’s t-test, * p ≤ 0.05. 623 
 624 
Figure 2 – Lamina protein dispersal to the cytoplasm is pSer404 Lamin A/C specific and the 625 
cytoplasmic structures do not contain histone proteins, NLS-targeted protein or Lamin B1. 626 
A – pSer404 Lamin A/C in suprabasal REKs co-stained with DAPI (DNA marker). Confocal z-section. 627 
B-C - pSer404 Lamin A/C in suprabasal REKs co-stained for Histone H2B (B) and Histone H3 (C). 628 
Epifluorescence images. 629 
D – Histone H2B-mCherry positive post-confluent REKs stained for pSer404 Lamin A/C. Maximum 630 
projection of confocal z-sections, scale bar = 10 µm. 631 
E – pSer404 Lamin A/C in suprabasal REKs co-stained for Ran GTPase. Confocal z- section, boxed area 632 
is enlarged. 633 
F - NLS-mCherry expressing REK co-stained with pSer404 Lamin A/C in suprabasal REKs. Maximum 634 
projection of confocal z-sections. 635 
G - Lamin B1 in suprabasal REKs co-stained with Akt1. Epifluorescence image.  636 
H - Post-confluent REK cultures co-stained for Akt1 and filaggrin. Scale bars = 20 µm. 637 
 638 
Figure 3 – Identification of Akt1 interactors and co-staining with Akt1 and pSer404 Lamin A in 639 
differentiating keratinocytes. 640 
A – Coomassie staining of IgG1 and Akt1 immunoprecipitate (IP).  641 
B - List of Akt1 interactors identified by LC-MS/MS of Akt1 co-immunoprecipitate. 642 
C – STRING analysis of interactors in (A). PTM = posttranslational modification. 643 
D-I - Suprabasal differentiating REKs with Akt1 or pSer404 Lamin A/C co-stained for actin (phalloidin) 644 
(D), Arp3 (E), COPS4 (F), Myh9 (G), Jup (H), STAMBP (I). Confocal z-sections, scale bars = 20 µm. 645 
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 646 
Figure 4 – Akt1 interactors in murine epidermis and in Akt1 immunoprecipitate. 647 
A-C - Neonatal wild-type murine epidermis stained for Akt1 or pSer404 Lamin A and co-stained for 648 
Myh9 (A), Ran (B), STAMBP (C). 649 
D – IgG1 and Akt1 immunoprecipitate immunoblotted for total Akt, actin, Arp3 and Myh9. 650 
E – IgG and phospho-(Ser/Thr) Akt substrate (pSubs) IPs immunoblotted for Myh9 and pSubs. 651 
F – Summary of Akt1 interactors identified by mass spectrometry in an Akt1 co-immunoprecipitate 652 
that were also detected to be dispersed with Akt1 and pSer404 Lamin A/C in REKs, murine epidermal 653 
sections, and confirmed by western blotting of Akt1 co-immunoprecipitate. 654 
 655 
Figure 5 – Disruption of cytoskeletal Akt1 target protein function affects nuclear lamina dispersal 656 
and nuclear size. 657 
A – DMSO, blebbistatin and latrunculin B treated REKs stained for pSer404 Lamin A/C. 658 
Epifluorescence images, scale bar = 50 µm. 659 
B – Number of cells with pSer404 Lamin A/C dispersal in DMSO, blebbistatin and latrunculin B 660 
treated REKs. % of DMSO control, >4 independent experiments, > 3 FOV per experiment, one-way 661 
ANOVA * p ≤ 0.05, ** p ≤ 0.01. 662 
C – pSer404 Lamin A/C intensity in DMSO, blebbistatin and latrunculin B treated REKs. % of DMSO 663 
control, 3 independent experiments, > 3 FOV per experiment, one-way ANOVA all comparisons non-664 
significant. 665 
D – Representative Hoechst 33342 Area of DMSO, blebbistatin and latrunculin B treated REKs. 666 
E - Mean Hoechst 33342  Area of DMSO, blebbistatin and latrunculin B treated REKs. % of DMSO 667 
control, 3 independent experiments, one-way ANOVA, ** p ≤ 0.01, *** p ≤ 0.001. 668 
F – Representative pSer404 Lamin A immunoblots of DMSO, blebbistatin and latrunculin B treated 669 
REKs.  670 
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G – pSer404 Lamin A level of all fragments and the ~50 kDa fragment. % of DMSO, 2 independent 671 
experiments, all comparisons ns. 672 
H – DMSO or CK666 treated REKs stained for pSer404 Lamin A/C. Epifluorescence images, scale bar = 673 
50 µm. 674 
I – Number of cells with pSer404 Lamin A/C dispersal in DMSO and CK666 treated REKs. 3 FOV, 675 
unpaired t-test * p ≤ 0.05. 676 
J – pSer404 Lamin A/C staining intensity in DMSO and CK666 treated REKs. 3 FOV, unpaired t-test * p 677 
≤ 0.05. 678 
K – Representative Hoechst 33342 area of DMSO and CK666 treated REKs. 679 
L - Median Hoechst 33342 area of DMSO and CK666 treated REKs. % of DMSO control, 2 680 
independent experiments, non-significant. 681 
M - Myh9 expression in Ctrl and Myh9 shRNA knockdown post-confluent REKs. Numbers are relative 682 
to GAPDH expression and normalised to Ctrl. 683 
N - Ctrl and Myh9 shRNA knockdown post-confluent REKs stained for pSer404 Lamin A/C. 684 
Epifluorescence images, scale bar = 50 µm. 685 
O – Number of cells with pSer404 Lamin A/C dispersal in Ctrl and Myh9 shRNA knockdown REKs. 4 686 
independent shRNA knockdown cell lines, >3 FOV per line, Mann-Whitney test, ** p ≤ 0.01. 687 
Representative of two independent experiments. 688 
P - pSer404 Lamin A/C staining intensity in control and Myh9 shRNA knockdown cells. 4 independent 689 
shRNA knockdown cell lines, >3 FOV per line, Mann-Whitney test non-significant. Representative of 690 
two independent experiments. 691 
Q – Representative Hoechst 33342 area of Ctrl and Myh9 shRNA knockdown REKs. 692 
R – Median Hoechst 33342 area in Ctrl and Myh9 shRNA knockdown REKs. 2 independent 693 
experiments, 4 independent shRNA knockdown cell lines, error bars = SD, Wilcoxon test, ** p ≤ 0.01. 694 
 695 
Figure 6 – Nuclear dynamics in differentiating REKs. 696 
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A - Images every 20 min of EGFP-Lamin A positive post-confluent REKs. 697 
B – Cross-sectional area EGFP-Lamin A positive nuclei over time. 698 
C – Kymographs (yt projection) of a EGFP-Lamin A positive nucleus over time. 699 
D – Xz projections of a EGFP-Lamin A positive nucleus. Labelled with nuclear volume. 700 
E – Xy and xz projections of confocal z-sections of post-confluent REKs stained for Lamin A and Lamin 701 
B1. Scale bar = 10 µm. 702 
F –Cross-sectional area of basal and suprabasal nuclei in post-confluent REKs. Two independent 703 
experiments, Welch’s t-test, **** p ≤ 0.0001. 704 
G-I – Intensity of DAPI (G), Lamin A (H) and Lamin B1 (I) staining in basal and suprabasal nuclei in 705 
post-confluent REK cultures. Welch's t test, ** p ≤ 0.01, **** p ≤ 0.0001. Representative of two 706 
independent experiments. 707 
J - Images every 15 min of Histone H2B-mCherry positive post-confluent REKs. 708 
K - Cross-sectional area over time in 45 Histone H2B-mCherry positive nuclei greater than 80 µm2. 709 
L – Kymograph (yt projection) of Histone H2B-mCherry over time; shrunken nucleus (top panels) and 710 
a nucleus that does not shrink (bottom panels). 711 
M - Xz projections of Histone H2B-mCherry positive nuclei labelled with nuclear volume.  712 
N – Histone H2B-mCherry positive nuclear volume before and after shrinkage. Wilcoxon test, * p ≤ 713 
0.05. 714 
 715 
Figure 7 – Lamin A cleavage in nuclear degradation and cytoskeletal protein inhibitors prevent 716 
nuclear shrinkage. 717 
A – EGFP-Lamin A post-confluent REKs stained for pSer404 Lamin A. Maximum projection of confocal 718 
z-sections, scale bar = 10 µm. 719 
B – Diagram of Lamin A primary protein structure, highlighting predicted cleavage sites (arrows) and 720 
N-terminal antigen for antibody (E1) and immunoblots of untransfected and EGFP-Lamin A 721 
transfected post-confluent REK lysates with antibodies directed to GFP and two Lamin A/C regions. 722 
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C - Post-confluent REKs stained for pSer404 Lamin A and the N-terminus of Lamin A/C. Single 723 
confocal plane, scale bar = 10 µm. 724 
D – DMSO, blebbistatin and latrunculin B treated REKs stained for Lamin B1. Scale bar = 50 µm. 725 
E-F – Number per FOV (E) and area (F) of shrunken Lamin B1 expressing nuclei in DMSO, blebbistatin 726 
and latrunculin B treated REKs. 2 experiments, 3 FOV/experiment, error bars = SD, two-way ANOVA, 727 
* p ≤ 0.05, ** p ≤ 0.01. 728 
G – DMSO, blebbistatin and latrunculin B treated REKs stained for loricrin. Scale bar = 100 µm. 729 
H – Number of loricrin positive cells per FOV in DMSO, blebbistatin and latrunculin B treated REKs. 730 
>3 experiments, 3 FOV/experiment, one-way ANOVA, ** p ≤ 0.01. 731 
I – Loricrin staining intensity in DMSO, blebbistatin and latrunculin B treated REKs. % of DMSO 732 
control, >3 experiments, 3 FOV/experiment, one-way ANOVA, *** p ≤ 0.001. 733 
J – Cell area of loricrin positive cells in DMSO, blebbistatin and latrunculin B treated REKs. >3 734 
experiments, 3 FOV/experiment, one-way ANOVA, ** p ≤ 0.01. 735 
K – DMSO and CK666 treated REKs stained for Lamin B1. Scale bars = 50 µm. 736 
L - Number of shrunken Lamin B1 expressing nuclei per FOV in DMSO and CK666 treatments. 3 FOV, 737 
all comparisons non-significant. 738 
M – Nuclear area of shrunken Lamin B1 expressing nuclei in DMSO and CK666 treatments. 3 FOV, all 739 
comparisons non-significant. 740 
 741 
 742 
Figure 8 – Myh9 knockdown disrupts nuclear degradation and differentiation. 743 
A - Ctrl and Myh9 shRNA knockdown post-confluent REKs stained for Lamin B1. Scale bar = 100 µm. 744 
B - Number of shrunken Lamin B1 expressing nuclei per FOV in Ctrl and Myh9 shRNA knockdown 745 
post-confluent REKs. 4 independent shRNA knockdown cell lines, >3 FOV per line, unpaired t-test, 746 
non-significant. 747 
C – Ctrl and Myh9 shRNA knockdown post-confluent REKs stained for loricrin. Scale bar = 100 µm. 748 
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D - Number of loricrin positive cells per FOV in Ctrl and Myh9 shRNA knockdown post-confluent 749 
REKs. 4 independent shRNA knockdown cell lines, >3 FOV per line, Mann-Whitney test, * p ≤ 0.05. 750 
E – Ctrl or Myh9 shRNA knockdown REK organotypics stained with hematoxylin and eosin (H&E). 751 
Arrows indicate retained nuclei, scale bar = 50 µm. 752 
F-G – Height of viable epidermis (F) and cornified layers (G) in H&E stained Ctrl and Myh9 shRNA 753 
knockdown organotypics. 2 organotypics per line, two independent Myh9 shRNA knockdown lines, 754 
>3 measurements per FOV, Welch’s t test, * p ≤ 0.05. 755 
H - Ctrl and Myh9 shRNA knockdown organotypics stained for DAPI and Myh9. Scale bar = 50 µm. 756 
I - Ctrl or Myh9 shRNA knockdown REK organotypics stained with DAPI. Dashed line marks dermal-757 
epidermal junction, dotted line indicates junction of granular and cornified layers and arrows 758 
indicate retained nuclei, scale bar = 50 µm. 759 
J - Ctrl or Myh9 shRNA knockdown REK organotypics stained for pSer404 Lamin A. Dashed line marks 760 
dermal-epidermal junction, scale bar = 50 µm. 761 
K – Number of nuclei with phosphorylated Lamin A/C dispersal per 100 µm of the dermal-epidermal 762 
(D-E) junction in Ctrl or Myh9 shRNA knockdown organotypics. 2 independent shRNA knockdown cell 763 
lines, 2 organotypics per cell line, >3 FOV per line, Mann-Whitney test, * p ≤ 0.05. 764 
L - Ctrl and Myh9 shRNA knockdown organotypics stained for loricrin. Scale bar = 50 µm. 765 
 766 








	
Supplementary	Figure	1	–	pSer404	Lamin	A	dispersal	and	loricrin	expression	in	REKs.		
A	–	Human	epidermal	sections	stained	for	pSer404	Lamin	A/C.	
B	–	Post-confluent	REK	cultures,	untreated	or	expressing	Myr-Akt1,	stained	for	pSer404	Lamin	A/C	and	Akt1.	
C	–	Number	of	cells	with	dispersed	pSer404	Lamin	A/C	in	control	or	Myr-Akt1	expressing	post-confluent	REK	
cultures.	10	FOV	per	construct,	unpaired	t-test,	**	p	≤	0.01.	
C	–	Number	of	cells	with	dispersed	pSer404	Lamin	A/C	in	control	or	Myr-Akt1	expressing	post-confluent	REK	
cultures.	10	FOV	per	construct,	unpaired	t-test,	**	p	≤	0.01.	
E	–	Post-confluent	REK	cultures	expressing	WT,	S404A	or	S404D	Lamin	A/C	stained	for	loricrin.	Scale	bar	=	100	µm.	
F	–	Number	of	loricrin	expressing	cells	in	REK	cultures	expressing	WT,	S404A	or	S404D	Lamin	A/C.	%	of	WT,	>	3	
FOV	per	experiment,	one-way	ANOVA,	all	comparisons	non-significant.		
G	–	Post-confluent	REK	cultures	expressing	WT	or	S404D	Lamin	A/C	stained	for	pSer404	Lamin	A/C.	Scale	bar	=	50	
µm.	
H	–	Number	of	cells	with	dispersed	pSer404	Lamin	A/C	in	post-confluent	REK	cultures	expressing	WT	or	S404D	
Lamin	A/C.	%	of	WT,	3	FOV	per	construct,	unpaired	t-test,	all	comparisons	non-significant.	
I	-	Area	of	Hoechst	33342	staining	of	WT	or	S404D	Lamin	A/C	expressing	REKs.	
J	–	Post-confluent	REK	cultures	expressing	WT,	S404A	or	S404D	Lamin	A/C	stained	for	FLAG.	Scale	bar	=	100	µm.	
	
	
	
	
	
	
	
	
	
Supplementary	Figure	2	–Akt1	interactor	identification	and	inhibition	of	cytoskeletal	candidates	is	required	for	
nuclear	size.	
A	–	Area	of	Hoechst	33342	signal	of	DMSO,	blebbistatin	and	latrunculin	B	treated	REKs,	replicate	experiment.	
B	-	Area	of	Hoechst	33342	signal	of	DMSO,	blebbistatin	and	latrunculin	B	treated	REKs,	replicate	experiment.	
C	-	Area	of	Hoechst	33342	signal	of	DMSO	and	CK666	treated	REK	cultures,	replicate	experiment.	
	
	
	
	
	
	
	
Supplementary	Figure	3	–	Live	imaging	of	nuclei	positive	for	Histone	H2B-mCherry	alone	and	with	EGFP-Lamin	
A.	
A	-	Cross-sectional	area	over	time	of	a	further	44	Histone	H2B-mCherry	positive	nuclei	greater	than	80	µm2.	
B	–	Number	of	Histone	H2B-mCherry	positive	nuclei	that	shrink	and	fade	during	imaging.	
C	-	Cross-sectional	area	over	time	of	Histone	H2B-mCherry	positive	nuclei	less	than	80	µm2.	
D	-	Cross-sectional	area	over	time	of	Histone	H2B-mCherry	and	EGFP-Lamin	A	positive	nuclei.	
E	-	Images	every	20	min	of	a	Histone	H2B-mCherry	and	EGFP-Lamin	A	positive	nucleus	in	post-confluent	REKs.	
F	–	Kymograph	(yt)	of	a	Histone	H2B-mCherry	and	EGFP-Lamin	A	expressing	nucleus.	
	
	
Supplementary	Figure	4	–	GFP-tagged	Lamin	A	dynamics	in	post-confluent	REKs.	
A	–	Untransfected	or	Lamin	A-mEmerald	expressing	post-confluent	REK	lysates	immunoblotted	for	GFP	or	the	N-
terminus	of	Lamin	A/C	(E1).	
B	–	Overexposed	blot	of	untransfected,	EGFP-Lamin	A	or	Lamin	A-mEmerald	expressing	post-confluent	REK	
lysates	immunoblotted	for	GFP.	
C	-	Diagram	of	Lamin	A	primary	protein	structure,	highlighting	predicted	cleavage	sites	(arrows),	Ser404,	N-
terminal	antigen	for	antibody	(E1),	relative	to	N-terminal	or	C-terminal	tags.	
D	-	Images	every	20	min	of	a	Lamin	A-mEmerald	positive	nucleus.	
E	-	Cross-sectional	area	over	time	of	Lamin	A-mEmerald	positive	nuclei.	
F	–	Kymograph	(yt)	of	a	Lamin	A-mEmerald	positive	nucleus.		
G	-	Xz	projections	of	a	Lamin	A-mEmerald	positive	nucleus.	Labelled	with	nuclear	volume.		
H	–	Lamin	A-mEmerald	positive	REKs	stained	for	pSer404	Lamin	A.	Confocal	z-section,	scale	bar	=	10	µm.	
I	–	Morphology	of	EGFP-Lamin	A	and	Lamin	A-mEmerald	positive	nuclei	in	the	first	30	min	of	imaging,	12	nuclei	
randomly	selected	from	12	FOV.	Sum	of	confocal	z-sections,	scale	bar	=	10	µm.	
J	–	Post-confluent	REK	cultures	treated	with	DMSO	or	caspase	inhibitor	Q-VD-Oph	stained	for	pSer404	Lamin	A/C.	
Scale	bar	=	20	µm.	
K	–	Number	of	cells	with	dispersed	pSer404	Lamin	A/C	in	post-confluent	REK	cultures	treated	with	DMSO	or	Q-
VD-Oph.	%	of	DMSO,	>10	FOV	per	construct,	unpaired	t-test,	non-significant.	
	
	
	
